Brief: Helius Medical Technologies Sees Q4 Revenue Up More Than 30 Percent
Jan 26 (Reuters) - Helius Medical Technologies Inc HSDT.O :
* SEES Q4 REVENUE $250,000 TO $260,000
* SEES Q4 REVENUE UP MORE THAN 30 PERCENT
* SEES INITIATION OF PIVOTAL CLINICAL TRIAL IN STROKE
PATIENTS IN
FIRST HALF OF 2022
* UNAUDITED YEAR END CASH BALANCE OF $11 MILLION
* Q4 REVENUE VIEW $110000.00 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX58Qmmw
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit